Oncological outcomes from trimodality therapy receiving definitive doses of neoadjuvant chemoradiation (≥60 Gy) and factors influencing consideration for surgery in stage III non-small cell lung cancer

PURPOSE: Guidelines for locally advanced non-small cell lung cancer (LA-NSCLC) recommend definitive chemoradiation therapy (CRT) for cN2-N3 disease, reserving surgery for patients with minimal nodal involvement at presentation. The current literature suggests that surgery after CRT for stage III NSC...

Descripción completa

Detalles Bibliográficos
Autores principales: Vyfhuis, Melissa A.L., Bhooshan, Neha, Burrows, Whitney M., Turner, Michelle, Suntharalingam, Mohan, Donahue, James, Nichols, Elizabeth M., Feliciano, Josephine, Bentzen, Søren M., Badiyan, Shahed, Carr, Shamus R., Friedberg, Joseph, Simone, Charles B., Edelman, Martin J., Feigenberg, Steven J., Mohindra, Pranshu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
ROI Value of RT Publication Award Winner
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5605306/
https://www.ncbi.nlm.nih.gov/pubmed/29114590
http://dx.doi.org/10.1016/j.adro.2017.07.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5605306/
https://www.ncbi.nlm.nih.gov/pubmed/29114590
http://dx.doi.org/10.1016/j.adro.2017.07.009

Ejemplares similares